Thinking of joining a study?

Register your interest

NCT06380114 | RECRUITING | Hpv


Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
Sponsor:

University of Rochester

Information provided by (Responsible Party):

Cynthia Rand

Brief Summary:

Each year in the U.S., ≥20,000 women and 14,000 men are affected by HPV-related cancers, including cervical and oropharyngeal cancer. However, in 2020, only 59% of U.S. adolescents aged 13-17 were up-to-date for HPV vaccination, and rates for 11-12 year olds, the primary target age group for HPV vaccination (when the immune reaction is better and before exposure to HPV infection), are even lower. Standing orders (written protocols that authorize designated members of the healthcare team to vaccinate without first obtaining a patient-specific physician order) have been shown to work in inpatient settings and for adults, but have not been evaluated for HPV vaccine, which some parents consider controversial. Also, the ways in which organizational readiness for change (resources, motivation, staff attributes, leadership support and culture) moderate the effect of standing orders has not been studied. A physician's recommendation is correlated with HPV vaccine acceptance, and the investigators have developed a successful online, interactive, communication education program that will be adapted to train nurses and staff in addition to physicians. The investigators propose testing standing orders for HPV vaccine in an Accountable Care Organization (ACO) in Western New York, and assessing which provider and practice factors moderate the effect of standing orders. Advantages of this setting include a diverse group of rural, urban and suburban practices, and the ACO provides data infrastructure and analytics that allow practices to evaluate vaccination rates in real time. Using a 2-arm cluster randomized trial (n=40 practices), the investigators will assess the effectiveness of standing orders (SO) + HPV communication education (intervention arm) relative to HPV communication education alone (control arm) on HPV vaccination for 9-17 year-olds.

Condition or disease

Hpv

Intervention/treatment

Communication

Standing Orders

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 16000 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
Actual Study Start Date : 2024-11-04
Estimated Primary Completion Date : 2026-04
Estimated Study Completion Date : 2027-11

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 9 Years to 17 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * active patient in AHP practice
Exclusion Criteria
  • * patient belonging to a practice with \>80% UTD baseline HPV vaccination rate for ages 13-17
  • * patient belonging to a practice with \<20 11-12 year-olds eligible for an HPV dose

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

Location Details

NCT06380114


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, New York

University of Rochester Medical Center (URMC)

Rochester, New York, United States, 14642

Loading...